CPT Code Overview

CPT 93453 describes a combined right and left heart catheterization procedure that includes intraprocedural injection(s) for left ventriculography and imaging supervision and interpretation when performed. This procedure is part of cardiology / cardiac catheterization procedures and is used to evaluate hemodynamics and left ventricular function during invasive diagnostic assessment.

Typical site of service: Hospital outpatient or inpatient setting. If additional information about billing context or place-of-service codes is required, Data not available in the input.

Clinical Context

A 68-year-old patient with exertional dyspnea, suspected pulmonary hypertension and suspected left ventricular dysfunction is admitted for invasive hemodynamic assessment. The interventional cardiology team performs a combined right and left heart catheterization to measure right- and left-sided pressures, cardiac output, and to perform left ventriculography during intraprocedural contrast injection. The procedure is performed in a hospital catheterization lab with monitoring by nursing and radiology technologists; imaging supervision and interpretation are documented by the physician. Findings guide diagnosis and management for conditions such as pulmonary hypertension, cardiomyopathy, or suspected post-infarction ventricular dysfunction.

Coding Specifications

• Modifier 26: Professional component — Use when billing the physician’s interpretation and reporting of the procedure separately from technical facility resources.

• Modifier TC: Technical component — Use when billing only the facility’s technical resources (equipment, technologist, radiology suite) for the procedure.

• Modifier 59: Distinct Procedural Service — Use when this procedure is separate and distinct from other services performed on the same day that would otherwise be considered bundled; documentation must support a separate procedural service.

• Modifier 51: Multiple Procedures — Use when multiple procedures are performed during the same session; appropriate when reporting more than one separate CPT procedure and payer policy requires this modifier.

Provider Taxonomies:

Related Diagnoses

• E85.81 — Cardiac amyloidosis

  Relevance: Cardiac amyloidosis can cause restrictive cardiomyopathy and heart failure; hemodynamic assessment and ventriculography from combined heart catheterization help evaluate ventricular function and filling pressures.

• E85.82 — Other amyloidosis of heart

  Relevance: Similar to cardiac amyloidosis, invasive hemodynamics and imaging guide assessment of myocardial involvement and ventricular performance.

• E85.89 — Other amyloidosis

  Relevance: Systemic amyloidosis with cardiac involvement may prompt combined right and left heart catheterization to assess cardiac effects.

• I27.20 — Primary pulmonary hypertension, unspecified

  Relevance: Right- and left-sided catheterization provides definitive hemodynamic measurements for diagnosis and management of pulmonary hypertension.

• I27.21 — Primary pulmonary hypertension, idiopathic

  Relevance: Invasive hemodynamic assessment is used for diagnosis, severity assessment, and treatment planning.

• I27.22 — Primary pulmonary hypertension, familial

  Relevance: Hemodynamic data from catheterization inform clinical management in familial pulmonary arterial hypertension.

• I27.23 — Primary pulmonary hypertension, drug- and toxin-induced

  Relevance: Right-heart catheterization quantifies pulmonary pressures and vascular resistance in suspected toxin-induced pulmonary hypertension.

• I27.24 — Primary pulmonary hypertension, chronic thromboembolic

  Relevance: Catheterization can assess pulmonary artery pressures and cardiac output in chronic thromboembolic pulmonary hypertension.

• I27.25 — Primary pulmonary hypertension, other

  Relevance: Used for other specified forms of pulmonary hypertension where invasive hemodynamic assessment is indicated.

• I27.29 — Other secondary pulmonary hypertension

  Relevance: Secondary causes of elevated pulmonary pressures prompt hemodynamic evaluation via combined catheterization.

• I50.810 — Left ventricular failure following acute myocardial infarction

  Relevance: Post-infarction ventricular dysfunction assessment may include left ventriculography as part of combined catheterization to evaluate ejection fraction and wall motion.

• I50.811 — Acute combined systolic and diastolic heart failure following acute myocardial infarction

  Relevance: Hemodynamic measurements and ventriculography inform severity and guide therapy.

• I50.812 — Acute systolic (congestive) heart failure following acute myocardial infarction

  Relevance: Left ventriculography during catheterization assesses systolic function after infarction.

• I50.813 — Acute diastolic (congestive) heart failure following acute myocardial infarction

  Relevance: Invasive assessment aids in differentiating systolic versus diastolic contributors to symptoms.

• I50.814 — Acute systolic and diastolic (congestive) heart failure following acute myocardial infarction

  Relevance: Comprehensive hemodynamic and ventriculographic data support management decisions.

• I50.82 — Chronic combined systolic and diastolic heart failure

  Relevance: Combined catheterization provides measurements of filling pressures and ventricular performance in chronic heart failure evaluation.

• I50.83 — Other chronic systolic (congestive) heart failure

  Relevance: Left ventriculography evaluates systolic dysfunction as part of invasive assessment.

• I50.84 — Other chronic diastolic (congestive) heart failure

  Relevance: Hemodynamic data help characterize diastolic dysfunction and guide therapy.

• I50.89 — Other heart failure

  Relevance: When heart failure etiology or severity is unclear, combined catheterization may be used diagnostically.

• I21.9 — Acute myocardial infarction, unspecified

  Relevance: Acute MI may prompt invasive coronary and ventricular assessment; combined catheterization can include ventriculography to assess ventricular function.

• I21.A1 — Myocardial infarction type 2

  Relevance: Hemodynamic assessment helps evaluate ischemic injury and cardiac function when MI type 2 is suspected.

• I21.A9 — Myocardial infarction type 3

  Relevance: Invasive assessment may be part of the evaluation when clinical presentation suggests myocardial infarction requiring catheter-based evaluation.

Related CPT Codes

Medicare's national mean allowed rate for CPT 93453 ($771.70) is lower than the BUCA (average commercial) mean ($1,096.91), representing a substantial gap between public and commercial benchmarks. Commercial payers generally report higher mean rates, with UnitedHealth Group and Cigna showing the highest national means.

Rate dispersion, measured as the difference between the 75th and 25th percentiles, varies across payers. Medicare displays a wide spread ($759.00) driven by a low 25th percentile, while Cigna and UnitedHealth Group also have large dispersions ($649.33 and $648.17 respectively). Aetna has one of the tighter distributions ($232.07), and BUCA and Blue Cross Blue Shield sit in the middle with moderate spreads ($463.43 and $501.47 respectively). The table and chart below present the full breakdown of mean rates and percentiles by payer.